Ionis Pharmaceuticals (IONS)

Ionis Pharmaceuticals (IONS) Financial Statements


Ionis Pharmaceuticals Financial Overview

Ionis Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.558; its P/E ratio is -17.77; Ionis Pharmaceuticals is scheduled to report earnings on May 1, 2024, and the estimated EPS forecast is $-1.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 324.50M$ 144.21M$ 110.51M$ 130.52M$ 151.89M
Gross Profit$ 321.44M$ 142.02M$ 415.80M$ -68.63M$ 148.20M
EBIT$ 1.79M$ -136.60M$ -75.16M$ -95.82M$ -38.61M
EBITDA$ 579.00K$ -137.23M$ -75.43M$ -93.77M$ -31.58M
Net Income Common Stockholders$ -1.35B$ 301.03M$ -85.29M$ -124.32M$ -52.43M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.33B$ 2.24B$ 2.39B$ 2.35B$ 1.99B
Total Assets$ 2.99B$ 2.93B$ 2.97B$ 2.89B$ 2.53B
Total Debt$ 257.04M$ 173.04M$ 175.02M$ 185.81M$ 1.37B
Net Debt$ -2.07B$ -2.06B$ -2.21B$ -2.16B$ -617.67M
Total Liabilities$ 2.60B$ 2.62B$ 2.54B$ 2.40B$ 1.96B
Stockholders Equity$ 386.69M$ 315.46M$ 428.30M$ 486.57M$ 572.89M
Cash Flow-
Free Cash Flow$ 32.91M$ -112.26M$ -110.44M$ -145.72M$ -205.20M
Operating Cash Flow$ 32.87M$ -109.02M$ -97.36M$ -133.99M$ -200.19M
Investing Cash Flow$ -26.71M$ 68.71M$ 69.52M$ -325.64M$ 212.15M
Financing Cash Flow$ 40.72M$ -32.27M$ 143.54M$ 492.09M$ -51.02M
Currency in USD

Ionis Pharmaceuticals Earnings and Revenue History

Ionis Pharmaceuticals Debt to Assets

Ionis Pharmaceuticals Cash Flow

Ionis Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis